Pharmacy to Dose: The Critical Care Podcast Nick Peters

December 2023 Literature Review Series
Special Guests: Jenna Self, PharmD
Hannah Millard, PharmD
 
04:30 – Featured Articles
38:45 – Cardiology
49:30 – Potpourri
53:20 – Sepsis
60:00 – PharmD
65:00 – Sweet Emotion
 
Reference List: https://pharmacytodose.com/wp-content/uploads/2024/05/december-2023-lrs-references.pdf

PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices

ACC 2024 Rapid Reaction: Part II
Special Guest: Snehal Bhatt, PharmD, BCPS, FASHP, AACC @SnayCardsPharmD
 
04:05 – EMPACT-MI
29:35 – ULTIMATE-DAPT
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/05/acc-2024-part-ii-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices

ACC 2024 Rapid Reaction: Part I
Special Guest: Ryan Caputo, PharmD, BCCP @RyanCaputo1
 
04:05 – DanGer Shock
29:15 – REDUCE-AMI
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/05/acc-2024-part-i-references-1.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices

Rapid Sequence Intubation (RSI): Part II
Special Guest: Christine Groth, PharmD, FCCM, BCCCP @GrothChristine
Angela Slampak-Cindric, PharmD, BCPS, BCCCP, FCCM @AngelaSlampak
Kevin Kaucher, PharmD, BCCCP
 
04:05 – Guideline development/involvement
12:50 – 2024 guideline overview
25:10 – Pharmacotherapy recommendations/considerations
42:40 – Non-pharmacologic recommendations/guideline insights
70:30 – Research ideas/conclusions
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/05/rsi-part-ii-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices

Trial of the Week: ESETT
Special Guest: Ashley McCormick, PharmD, BCPS, BCCCP
 
Ashley McCormick joins to discuss the April Trial of the Week “Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus” the ESETT study, published in NEJM in 2019.
We set the scene by reviewing ASM PK/PD properties and discussing if there was a standard of care first-line treatment. Then we do a deep dive into the ESETT trial of the week. Did the 75kg dose cap influence results? How appropriate was the BZD dosing? How does this % of seizure cessation compare to other studies? Where did this dosing scheme come from? Trial fun facts, medication safety considerations, and much, much more.
Reference list: https://pharmacytodose.files.wordpress.com/2024/04/esett-trial-of-the-week-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices

Thrombolytic Dosing in PE: Versus Series
Special Guest: Lauren Igneri, PharmD, BCPS, BCCCP, FCCM
 
05:20 – High-risk PE
23:00 – Intermediate-risk
37:10 – Cardiac arrest
52:30 – Closing arguments
57:15 – Bonus: TNK v. tPA
 
Reference List: https://pharmacytodose.files.wordpress.com/2024/04/thrombolytic-dosing-in-pe-references.pdf
 
PharmacyToDose.Com
@PharmacyToDose
PharmacyToDose@Gmail.com
Learn more about your ad choices. Visit megaphone.fm/adchoices